; and (B) a certification that such data is accurate. (2) Later submissions Any manufacturer of insulin that does not submit the information described in paragraph (1) by the date described in such paragraph may later submit the information described in subparagraphs (A) and (B) of paragraph (1) to the Secretary. Such a manufacturer who submits such information pursuant to this paragraph is eligible to certify its list price for the applicable insulin under subsection (b)(2)(A)(ii) with respect to the first plan year that begins at least 15 months after the date of submission under this paragraph. (b) Annual price certification (1) In general Any manufacturer of insulin who submits information in accordance with subsection (a) is eligible for certification under this subsection. (2) Requirements (A) First certification (i) Initial eligibility for certification A manufacturer of insulin who submits information under subsection (a)(1) is considered certified under this subsection for plan year 2022 if such manufacturer, not later than September 30, 2020, submits to the Secretary a certification that the manufacturer reduced its list price for insulin to an amount that is no greater than the list price for the same insulin that applied as of July 1, 2006. (ii) Later certification A manufacturer of insulin that submitted information under subsection (a)(2) not later than September 30 of the calendar year that is 2 years prior to the applicable plan year, is considered certified under this subsection for the applicable plan year if such manufacturer submits to the Secretary a certification, not later than September 30 of such calendar year, that the manufacturer reduced its list price for insulin to the amount that is no greater than the list price for the same insulin that applied as of July 1, 2006, increased by not more than the rate by which the medical care component of the consumer price index for all urban consumers (U.S. city average) increased between September 30, 2020, and the date on which the